gohiam.com
Pictet Group
Edit

Pictet Group

https://www.pictet.com/
Last activity: 14.07.2026
Active
Pictet is an investment-led service company, offering wealth management, asset management and related services. We are a partnership of eight owner managers and our principles of succession and transmission of ownership have remained unchanged since founding in 1805. Our purpose is to build responsible partnerships with our clients, communities, and the companies in which we invest, in order to safeguard and transmit wealth, of all kinds, in the service of the real economy. With more than CHF 612 billion in assets under management or custody at 31 December 2022, Pictet is today one of the leading Europe-based independent wealth and asset managers. The Group is headquartered in Geneva, where its activities began, and employs more than 5000 employees. With 30 offices, it is also present in Amsterdam, Basel, Barcelona, ​​Brussels, Dubai, Frankfurt, Hong Kong, Lausanne, London, Luxembourg, Madrid, Milan, Monaco, Montreal, Munich, Nassau, Osaka, Paris, Rome, Shanghai, Singapore, Stuttgart, Taipei, Tel-Aviv, Tokyo, Turin, Verona, Shanghai, New York and Zurich.
Followers
89.02K
Portfolio
2
Mentions
67
Employees: 5001-10000
Founded date: 1805
Investment Stage: Series A; Series B

Portfolio 2

DateNameWebsiteTotal RaisedLocation
12.01.2026Kinaset Th...kinasettx.com$103MUnited Sta...
24.12.2025Syremis Th...syremis.com$165MUnited Sta...

Mentions in press and media 67

DateTitleDescription
14.07.2026Pictet Raises $253 Million For First Environment Co-Investment FundPictet Alternative Advisors announced the final close of Environment Co-Investment Fund I, raising $253 million in committed capital. The fund closed above its $200 million target. Environment Co-Investment Fund I is Pictet’s first dedicate...
10.07.2026Unique Secures USD $30 Million Series A to Pioneer Agentic AI Workforce in Financial ServicesThe USD $30m Series A round led by CommerzVentures and DN Capital saw continued participation from VI Partners and Pictet Group The Zurich-based startup is at the forefront of responsible agentic AI innovation for Asset Management, Wealth M...
02.04.2026Asian stocks slide, oil rises after Trump speech on Iran warSINGAPORE: Markets recoiled on Thursday (Apr 2) as war jitters over Iran deepened, with stocks sliding, oil surging well over US$100 per barrel and the dollar firming after US President Donald Trump dashed hopes for clarity on when the Midd...
28.03.2026Pictet Alternative Advisors: €403 Million Raised For First Direct Private Equity StrategyPictet Alternative Advisors has announced the final close of its first direct private equity strategy, Pictet Private Equity Entrepreneur Capital I, at €403 million, marking a significant expansion of the firm’s direct investing capabilitie...
22.03.2026Wealthy consumers are turning to jewelry as an investment, especially colored gemstonesWealthy consumers are increasingly buying jewelry, as market volatility and geopolitical uncertainty push investors toward tangible assets. Resale markets and lofty gold prices have reinforced jewelry’s reputation as a long-term store of va...
17.02.2026Axis Max Life Reports 20% YoY Growth in Individual Adjusted First Year Premium in 9M FY'26; VNB Increases by 30% YoYNoida, Uttar Pradesh, India 9-Months Financial Year 2026 (“9M FY’26”) Highlights: Max Financial Services Limited reports 18% growth in consolidated revenue excluding investment income Axis Max Life continues outperforming private industry; ...
13.01.2026Kinaset Therapeutics Secures $103M for Severe Asthma Drug AdvancementKinaset Therapeutics obtained $103 million in Series B funding. This capital fuels the development of frevecitinib. Frevecitinib is an innovative inhaled pan-JAK inhibitor. It targets severe asthma and other serious respiratory diseases. Th...
12.01.2026Kinaset Therapeutics Raises $103M in Series B FundingKinaset Therapeutics, a Boston, MA-based clinical-stage biopharmaceutical company, raised $103M in Series B funding. The round was led by RA Capital Management and Forge Life Science Partners, with participation from new investors EQT Life ...
12.01.2026EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseasesEQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases Mon, Jan 12, 2026 13:00 CET Report this content EQT Life Sciences invests in U.S.-based Kinaset Thera...
10.01.2026Kinaset Therapeutics: $103 Million Series B Closed To Advance Inhaled Pan-JAK Drug For Severe AsthmaKinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing inhaled therapies for severe respiratory diseases, announced it has closed a $103 million oversubscribed Series B financing to fund mid-stage development...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In